Pharmalot
Taking stock of the drug industry, from the lab to the medicine chest. Sign up for the newsletter here.
Most Read
After a court let them off the hook, generic Zantac makers plan to seek legal expenses from consumers
Biogen trials for Alzheimer’s drug excluded much of the targeted patient pool, study finds
FDA commissioner, two senators raise concerns about patent abuse by pharmaceutical companies
Cancer drug indications remain on labels even after trials fail to confirm their benefits
A ‘wonky’ congressional report will be a pharma talking point in the drug pricing debate
Pharmalittle: Contaminants found in Moderna Covid-19 vaccine in Japan; demand rises for ivermectin to treat the coronavirus
Safety-net hospitals take big markups on cancer drugs for commercially insured patients, study finds
All Coverage
advertisement
